1. Study included 386 patients with CSU and CIndU.
2. CSU patients had lower quality of life (DLQI mean score 8.3) compared to CIndU patients (DLQI mean score 6.
3. 3. 10.6% of CSU patients faced high outpatient costs.
4. Awareness of biologics was limited; cost was a significant barrier.
5.  CSU patients more likely to require chaperones during visits.
6. Younger age & education linked to better knowledge of biologics. 7. Need for tailored approaches in managing CSU.

Source: Journal of Dermatological Treatment